Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed Sep 7, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-09-06$26.54/sh−4,664$123,774→ 301,563 total(indirect: By Trust) - Tax Payment
Common Stock
2022-09-02$26.38/sh−519$13,691→ 17,143 total - Sale
Common Stock
2022-09-06$27.14/sh−336$9,118→ 301,227 total(indirect: By Trust)
Holdings
- 50,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F3]The price reported is a weighted-average price. The shares were sold at prices ranging from $26.04 to $27.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The price reported is a weighted-average price. The shares were sold at prices ranging from $27.09 to $27.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.